Home/Filings/4/0000899243-21-006358
4//SEC Filing

PASSERI DANIEL R 4

Accession 0000899243-21-006358

CIK 0001645460other

Filed

Feb 11, 7:00 PM ET

Accepted

Feb 12, 5:47 PM ET

Size

5.4 KB

Accession

0000899243-21-006358

Insider Transaction Report

Form 4
Period: 2021-02-10
PASSERI DANIEL R
DirectorCHIEF EXECUTIVE OFFICER
Transactions
  • Award

    Stock Option (right to buy)

    2021-02-10+85,00085,000 total
    Exercise: $15.55Exp: 2031-02-09Common Stock (85,000 underlying)
Footnotes (1)
  • [F1]This stock option grant becomes exercisable in eight equal semi-annual installments beginning August 10, 2021.

Issuer

Cue Biopharma, Inc.

CIK 0001645460

Entity typeother

Related Parties

1
  • filerCIK 0001190121

Filing Metadata

Form type
4
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 5:47 PM ET
Size
5.4 KB